Geberit Ag:企業の戦略・SWOT・財務分析

◆英語タイトル:Geberit Ag - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3052
◆発行会社(調査会社):MarketLine
◆発行日:2019年11月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:Construction
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥23,275見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥46,550見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥69,825見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Geberit Ag – Strategy, SWOT and Corporate Finance Report
Summary

Geberit Ag – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Geberit AG (Geberit) is a manufacturer of sanitary products and bathroom ceramics. The company’s key offerings include faucets and flushing systems, traps and drains, ceramics and pipes and fittings for the construction of new buildings, renovation and modernization projects. It develops, manufactures and markets sanitary products and systems for the residential, commercial, and industrial construction markets worldwide. The company provides training on the products and software tools for plumbers, sanitary engineers and architects in various information centers. It has sales offices in several countries and owns production sites in Germany, Switzerland, Beneleux, Italy, the UK and Ireland. Geberit is headquartered in Rapperswil-Jona, Switzerland.

Scope

- Detailed information on Geberit Ag required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Geberit Ag in the form of a SWOT analysis
- An in-depth view of the business model of Geberit Ag including a breakdown and examination of key business segments
- Intelligence on Geberit Ag’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Geberit Ag, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Geberit Ag and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Geberit Ag as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Geberit Ag’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Geberit AG: Company Overview
Geberit AG: Overview and Key Facts
Geberit AG: Overview
Geberit AG: Key Facts
Geberit AG: Key Employees
Geberit AG: Key Employee Biographies
Geberit AG: Major Products and Services
Geberit AG: Company History
Geberit AG: Management Statement
Geberit AG: Locations and Subsidiaries
Geberit AG: Key Competitors
Geberit AG: Company Analysis
Geberit AG: Business Description
Geberit AG: SWOT Analysis
Geberit AG: SWOT Overview
Geberit AG: Strengths
Geberit AG: Weaknesses
Geberit AG: Opportunities
Geberit AG: Threats
Geberit AG: Corporate Financial Deals Activity
Geberit AG: Financial Deals Overview
Geberit AG: Top Deals 2015 – 2019YTD*
Geberit AG: Mergers and Acquisitions
Geberit AG: Divestments
Geberit AG: Recent Developments
Geberit AG: News and Events Summary
Geberit AG: Corporate Governance
Geberit AG: Financial Performance
Geberit AG: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Geberit AG: Key Facts
Table 2: Geberit AG: Key Employees
Table 3: Geberit AG: Company History
Table 4: Geberit AG: Locations and Subsidiaries
Table 5: Geberit AG: Key Competitors
Table 6: Geberit AG: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 7: Geberit AG: M&A Average Deal Size - Value (US$m)
Table 8: Geberit AG: Top Deals 2015 - 2019YTD*
Table 9: Geberit AG: M&A Volume and Value Trend (2015 - YTD*2019)
Table 10: Geberit AG: M&A Activity by Geography (2015 - YTD*2019)
Table 11: Geberit AG: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 12: Geberit AG: Divestments by Geography (2015 - YTD*2019)
Table 13: Geberit AG: News and Events Summary
Table 14: Geberit AG: Corporate Governance
Table 15: Geberit AG: Financial Performance
Table 16: Geberit AG: Strategy and Operations

★海外企業調査レポート[Geberit Ag:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds 2P reserves of 21.4 mmbo and has an oil production of barrels from Blocks in Sultanate of Oman. It also holds onshore explorati …
  • Bio Blast Pharma Ltd (ORPN):企業の財務・戦略的SWOT分析
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …
  • NantKwest Inc (NK):企業の財務・戦略的SWOT分析
    Summary NantKwest Inc (NantKwest), a subsidiary of NantWorks LLC, develops natural killer (NK) cell therapies to treat cancer, infectious and inflammatory diseases by harnessing the immune system. The company is developing drugs against Merkel cell carcinoma 2L, non-small cell lung cancer 3L, multip …
  • Shinhan Financial Group Co Ltd:戦略・SWOT・企業財務分析
    Shinhan Financial Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shinhan Financial Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tandem Diabetes Care Inc (TNDM):医療機器:M&Aディール及び事業提携情報
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect applicat …
  • Newhaven Hotels Limited:企業の戦略・SWOT・財務分析
    Newhaven Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Newhaven Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Freeport-McMoRan Inc:戦略・SWOT・企業財務分析
    Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report Summary Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Star Gas Partners L.P.:企業の戦略・SWOT・財務情報
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Applied Industrial Technologies, Inc.:戦略・SWOT・企業財務分析
    Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Applied Industrial Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • ROHM Co Ltd (6963):企業の財務・戦略的SWOT分析
    ROHM Co Ltd (6963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Energy Resources of Australia Ltd. (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd. (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • Syndicate Bank Ltd (SYNDIBANK):企業の財務・戦略的SWOT分析
    Syndicate Bank Ltd (SYNDIBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Onxeo SA:企業のM&A・事業提携・投資動向
    Onxeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Onxeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Illumina Inc (ILMN)-医療機器分野:企業M&A・提携分析
    Summary Illumina, Inc. (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; micro …
  • Celon Pharma SA (CLN)-製薬・医療分野:企業M&A・提携分析
    Summary Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutic …
  • UCB S.A.:企業の戦略・SWOT・財務分析
    UCB S.A. - Strategy, SWOT and Corporate Finance Report Summary UCB S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • GI Dynamics Inc (GID)-製薬・医療分野:企業M&A・提携分析
    Summary GI Dynamics Inc (GI Dynamics) is a medical device company that develops and commercializes endoscopy instruments. The company’s product includes EndoBarrier, an endoscopically delivered device therapy that is designed to mimic the mechanisms of metabolic surgery- without altering the anatomy …
  • SciBase AB (SCIB):医療機器:M&Aディール及び事業提携情報
    Summary SciBase AB (SciBase) is a medical technology company that offers non-invasive detection and monitoring of skin tissue alterations. The company develops point of care device for the accurate detection of malignant melanoma. It offers electrical impedance spectroscopy which uses the varying el …
  • Halewood International Holdings PLC:企業の戦略・SWOT・財務情報
    Halewood International Holdings PLC - Strategy, SWOT and Corporate Finance Report Summary Halewood International Holdings PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆